Drug intelligence / Profile preview

Kaixin Changyu Granule

Development stage
Unknown
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Kaixin Changyu Granule is a traditional Chinese medicine (TCM) formulation developed for the treatment of post-stroke depression. It is administered in granule form and used as an adjunct or alternative to conventional antidepressant therapies, particularly in patients recovering from stroke. The mechanism of action is not fully elucidated but, consistent with many TCM products for neuropsychiatric indications, it likely involves modulation of neurotransmitter systems and neuroprotective effects through multi-component herbal ingredients. The product is currently being studied in clinical trials to evaluate its efficacy and safety for post-stroke depression[8].

Brand names
Kaixin Changyu Granule
Other names
Kaixin Changyu Granule
02

Targets

SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on Kaixin Changyu Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaixin Changyu Granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call